Velorum Therapeutics
Winter 2024 · Active
Breakthrough medicines unlocking the biology of heme
This profile is part of our independent Y Combinator directory. Data is compiled from public sources and paired with research guides — verify details on the company's official website or YC listing before making business decisions. See our Disclaimer.
Location: San Francisco, US
Founded: 2023
Team size: 5
About
Velorum Therapeutics is developing breakthrough medicines by unlocking the biology of heme.
Founders
Pouya ModareszadehFounder
Co-Founder & CEO @ Velorum Therapeutics. BS in Biology, University of Texas at Dallas. Building new medicines.
Parsa ModareszadehFounder
Co-Founder and President @ Velorum Therapeutics. Goldwater Scholar. Working to create breakthrough medicines for devastating diseases.
Company ID: 29429 · Look up by ID